Thurston Springer Miller Herd & Titak Inc. Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,913 shares of the medical equipment provider’s stock after acquiring an additional 755 shares during the period. Thurston Springer Miller Herd & Titak Inc.’s holdings in Intuitive Surgical were worth $998,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Park Avenue Securities LLC lifted its stake in shares of Intuitive Surgical by 5.2% during the 4th quarter. Park Avenue Securities LLC now owns 15,724 shares of the medical equipment provider’s stock worth $8,207,000 after purchasing an additional 784 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Intuitive Surgical by 9.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,571,273 shares of the medical equipment provider’s stock worth $820,142,000 after purchasing an additional 129,363 shares in the last quarter. Board of the Pension Protection Fund purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $1,044,000. Fifth Third Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 10.9% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 9,245 shares of the medical equipment provider’s stock valued at $4,826,000 after buying an additional 907 shares in the last quarter. Finally, SeaCrest Wealth Management LLC grew its position in shares of Intuitive Surgical by 2.2% in the 4th quarter. SeaCrest Wealth Management LLC now owns 1,982 shares of the medical equipment provider’s stock worth $1,035,000 after buying an additional 42 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, Leerink Partners increased their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Stock Up 7.7 %

Intuitive Surgical stock opened at $580.11 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $584.60. The firm has a market cap of $206.62 billion, a price-to-earnings ratio of 93.27, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The business’s 50-day moving average price is $537.05 and its 200 day moving average price is $496.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.